Telehealth After COVID-19

Clarifying Policy Goals for a Way Forward

by Lori Uscher-Pines, Monique Martineau

Download Free Electronic Document

FormatFile SizeNotes
PDF file 0.2 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Although clinicians have experimented with telehealth for years, it did not become mainstream until the coronavirus disease 2019 pandemic curtailed in-person health care services. The growth of telehealth services—spurred by temporary changes that are intended to help prioritize and maintain both access to care and adherence to social distancing guidelines—has policymakers, payers, and advocates rethinking the role that they would like telehealth to play in a post-pandemic health care system. The authors of this Perspective present considerations for how telehealth could benefit (or detract) from several policy goals. They also offer recommendations for how policymakers might use the tools at their disposal to achieve their post-pandemic goals.

Research conducted by

Funding for this Perspective was provided by gifts from RAND supporters and income from the operation of RAND Health Care. This research was carried out within the Access and Delivery Program in RAND Health Care.

This publication is part of the RAND Corporation Perspective series. RAND Perspectives present expert insights on timely policy issues. All RAND Perspectives undergo peer review to ensure high standards for quality and objectivity.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.